RegeneRx Biopharmaceuticals' PIPE Round

RegeneRx Biopharmaceuticals raised a round of funding on December 21, 2006.

RegeneRx is a publicly traded, clinical-stage, biopharmaceutical company engaged in the design, research and development of novel peptides targeted at diseases with unmet medical needs. RegeneRx's mis…

Articles about RegeneRx Biopharmaceuticals' PIPE Round: